Cordant Inc’s GE HealthCare GEHC Stock Holding History

Cordant Inc’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12	Closed	-$929	–	96
2023 Q4	$929	Buy	+12	New	+$840	﹤0.01%	125

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cordant Inc's GEHC Position: Q1 2024 in Review

Cordant Inc sold out of GE HealthCare (GEHC) in Q1 2024, closing a stake of 12 shares — an estimated $929 sold.

Cordant Inc first reported a position in GEHC in Q4 2023 and held it in 1 quarter. The position peaked at $929 in Q4 2023. 1,258 funds tracked by Wall St. Rank hold GEHC as of Q1 2024.

Cordant Inc reported no remaining GE HealthCare position as of Q1 2024 after selling out during the quarter.
Cordant Inc sold 12 GE HealthCare shares in Q1 2024, an estimated $929.
Cordant Inc first reported a position in GE HealthCare in Q4 2023 and held it in 1 quarter.
Cordant Inc's GE HealthCare position peaked at $929 in Q4 2023.
1,258 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2024.

Based on Cordant Inc's 13F filing for Q1 2024, filed 16 Apr 2024.